Denmark· DK-28105539514
Elocta
A coagulation factor viii product containing efmoroctocog alfa, registered in Denmark by Swedish Orphan Biovitrum AB. The same ATC class is registered in 11 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Coagulation factor viii is registered in 11 of 19 countries.
Countries holding a registration under ATC B02BD02 (coagulation factor viii), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 7 of them publish a price we can compare per daily dose
Coagulation factor viii · ATC B02BD02
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- efmoroctocog alfa
- Manufacturer
- Swedish Orphan Biovitrum AB
- Country
- Denmark (DK)
- ATC code
- B02BD02
- ATC class
- Coagulation factor VIII
- Defined daily dose
- 1 TSD, E
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28105539514
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
4 interactions on record for coagulation factor viii.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Coagulation factor viii · interactions on record
4 records
- 2 severe
- 2 moderate
Most severe, free to view
- CarfilzomibL01XG02severe
- CarfilzomibL01XX45severe
- PegvaliaseA16AB19moderate
- EmicizumabB02BX06moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under B02BD02
Coagulation factor viii, as other registers publish it.
- PolandAdvateTakeda Manufacturing Austria AG
- IcelandAdvateTakeda Manufacturing Austria AG
- PolandAdvateTakeda Manufacturing Austria AG
- PolandAdvateTakeda Manufacturing Austria AG
- PolandAdvateTakeda Manufacturing Austria AG
- FinlandAdvateAbacus Medicine A/S
- PolandAdvateTakeda Manufacturing Austria AG
- IcelandAdvateTakeda Manufacturing Austria AG
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/df140d25-7f80-44d3-8da7-e6becd5d01d8 GET /v1/drugs/df140d25-7f80-44d3-8da7-e6becd5d01d8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "pulver og solvens til injektionsvæske, opløsning",
"source": "dkma",
"strength": "250 IU",
"auth_role": "MOD",
"dk_drugid": "28105539514",
"substance": "efmoroctocog alfa",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "42327"
}See everything about coagulation factor viii.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.